Page last updated: 2024-08-18

chalcone and Diabetic Glomerulosclerosis

chalcone has been researched along with Diabetic Glomerulosclerosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Adelusi, T; Chowdhry, A; Du, L; Gu, X; Hao, M; Li, X; Lu, Q; Sun, Y; Xu, L; Yin, X; Zhou, X1
Aiebchun, T; Chavasiri, W; Kaewin, S; Korkut, GG; Muanprasat, C; Patrakka, J; Poolsri, W; Rungrotmongkol, T; Sukanadi, IB; Sungkaworn, T1
Chen, R; Fang, Q; Jin, Y; Khan, Z; Li, W; Liang, G; Liu, Z; Shan, X; Wang, Y; Yu, W; Zou, C1
Chu, C; Li, H; Mi, J; Quan, S; Wang, Q; Wang, X; Wen, Z; Xu, Y; Zhang, S1

Reviews

1 review(s) available for chalcone and Diabetic Glomerulosclerosis

ArticleYear
Effect of safflower yellow on early type II diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials.
    Journal of pediatric endocrinology & metabolism : JPEM, 2019, Jul-26, Volume: 32, Issue:7

    Topics: Chalcone; Diabetes Mellitus; Diabetic Nephropathies; Humans; Incidence; Prognosis; Randomized Controlled Trials as Topic

2019

Other Studies

3 other study(ies) available for chalcone and Diabetic Glomerulosclerosis

ArticleYear
Novel Chalcone BDD-39 Mitigated Diabetic Nephropathy through the Activation of Nrf2/ARE Signaling.
    Current molecular pharmacology, 2022, Volume: 15, Issue:4

    Topics: Animals; Biphenyl Compounds; Chalcone; Chalcones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrosis; Mice; NF-E2-Related Factor 2; Oxidative Stress; RNA; Signal Transduction

2022
A sulfonamide chalcone AMPK activator ameliorates hyperglycemia and diabetic nephropathy in db/db mice.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 165

    Topics: AMP-Activated Protein Kinases; Animals; Calcium; Chalcone; Chalcones; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Humans; Hyperglycemia; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Molecular Docking Simulation

2023
Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys.
    British journal of pharmacology, 2019, Volume: 176, Issue:14

    Topics: Animals; Cells, Cultured; Chalcone; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Kidney; Lymphocyte Antigen 96; Mice; Mice, Inbred C57BL; Mice, Knockout; Renin-Angiotensin System; RNA, Small Interfering; Streptozocin

2019